Home / 2025 (Page 23)

In a major step toward strengthening primary healthcare delivery, BJP MP Rekha Gupta announced that 187 Ayushman Arogya Mandirs will be established across Delhi by December 2025. The initiative is part of the government’s commitment to providing accessible, affordable, and quality healthcare to every citizen

READ MORE

Elon Musk-led Starlink, the satellite internet division of SpaceX, is inching closer to its long-awaited India launch with a major partnership in Maharashtra aimed at boosting digital access across healthcare centers and remote regions. According to officials familiar with the development, Starlink has begun pilot connectivity

READ MORE

In a significant medical advancement, researchers at a Gurugram-based institute have reported a major breakthrough in the treatment of children suffering from Sickle Cell Disease (SCD), a genetic blood disorder that affects the shape and function of red blood cells. The institute’s clinical research team has

READ MORE

Investment to expand manufacturing and global medicine supply capacity — resonating with the Make in India agenda Eli Lilly and Company today announced plans to invest more than $1 Billion over the next several years into new contract manufacturing in India, expanding patients’ access to innovative

READ MORE

Kolkata, 10th November: World Immunisation Day is observed on 10th November every year, and the theme this year is ‘Immunisation for All is Humanly Possible’. World Immunization Week 2025 intends to ensure that more adolescents, children and adults, as well as their communities, are protected

READ MORE

The Vascular Surgeons Association of Karnataka (VASKAR) organized the Walkathon 2025 today in Bengaluru under the inspiring theme “Amputation-Free India.” Over 500 doctors, vascular specialists, and paramedical professionals came together at Freedom Park, walking to Vidhana Soudha to raise awareness on preventing avoidable amputations through early diagnosis and vascular care.The event was graced by Shri

READ MORE

Dementia India Alliance (DIA), a national, NGO dedicated to promoting awareness, advocacy, and care for people living with dementia, and Apollo AyurVAID Hospitals, India’s leading Precision Ayurveda hospital network under the Apollo Hospitals Group, have joined hands to advance integrative dementia care and awareness in

READ MORE

This world-class eye care facility has been built at an investment of around Rs 75 crore. With this expansion, Sankara Eye Hospital, Pedakakani, Guntur, aims to double its annual free eye surgeries from 30,000 to 60,000 for economically weaker sections. The new facility, built

READ MORE

Second quarter revenue from operations grows 4% sequentially and 2% year-on-year to Rs. 911 Cr 1st half revenue from operations up 6% Syngene International Limited today announced financial results for the second quarter and half year of FY26.   Quarterly Financial Highlights (All numbers are in Indian Rupees in Cr except margins)   Q2 FY25Q2 FY26YoY Change (%)Revenue from Operations8919112%Reported Revenue9089262%Reported EBITDA261215-18%Reported EBITDA margin (%)28.8%23.2% Reported PAT (before exceptional items)10667-37%Reported PAT Margin (%)11.7%7.3% H1 FY26 Financial Highlights (All numbers are in Indian rupees in Crores except margins)   H1 FY25H1 FY26YoY Change (%)Revenue from Operations1,6811,7856%Reported Revenue1,7151,8186%Reported EBITDA449439-2%Reported EBITDA margin (%)26.2%24.1% Reported PAT (before exceptional items)161*154-4%Reported PAT Margin (%)9.4%8.5% Excludes exceptional item of Rs. 21 crores (net of tax) in Q1 FY25 relating to final settlement from an insurance claim.   Commenting on the results, Peter Bains, Managing Director and CEO, Syngene International Limited, said, “Our Q2 performance was driven by underlying revenue growth from research

READ MORE

The approvals strengthen India’s position as a reliable supplier of advanced pharmaceuticals across ASEAN markets where Venus Remedies already exports more than 374 products. Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), among the 10 leading fixed-dosage injectable manufacturers in the world, has secured new marketing authorizations

READ MORE